CClinicalTrials.gg
WithdrawnNCT04395976Updated Mar 2, 2021

Ayurveda as Prophylaxis for Suspected COVID-19 Patients

An interventional study of Ayurveda in Covid-19, sponsored by British Ayurvedic Medical Council. Withdrawn at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-02.

Sponsored by British Ayurvedic Medical Council · Not applicable, Interventional, and Prevention

Why this study was withdrawn
Ethical approval was denied
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Despite worldwide efforts to contain, manage and treat Covid-19, the pandemic is continuing to spread. This calls for an urgent clinically-proven prophylaxis and therapeutic strategy. Recent developments on the use of traditional medicines in Covid-19 management has drawn enough attention to start several research studies. Based on the Indian Traditional Medicine, Ayurveda's community initiatives, preliminary studies, and our experiential knowledge on Covid-19 settings, we propose present study to prevent the development of COVID-19 symptoms in people who live or have come contact with an individual diagnosed with COVID-19.

02

Conditions studied

  • Covid-19

Browse trials for

Keywords

  • Ayurveda
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

Browse COVID-19 studies →

Lead sponsor

This is the only study on the registry with British Ayurvedic Medical Council as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Person who has come into contact with confirmed COVID-19,
  • Willing to take study drug as directed

Exclusion criteria

Exclusion Criteria:

  • Confirmed current COVID-19
  • Inability to take medications orally
  • Inability to provide written consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • No intervention
    Control Group

    Participants randomised into the control group receive conventional standard care given by recommended guideline.

  • Experimental
    Ayurveda

    Treatment includes a tailored combination of herbs based on individual constitution (based on Ayurveda) nutritional advice, specific consideration of selected food items, specific lifestyle advice, yoga advice along with standard recommendations.

    Other: Ayurveda

Interventions

  • OtherAyurveda

    The Ayurveda intervention is multimodal and following the principles of Ayurveda as a whole medical system, each participants will be treated with individualised care. From the range of proven Ayurvedic Herbs, combination will be decided based on individual participants, his symptoms and his personality.

06

What researchers measure

Primary outcomes

  1. Clinical confirmation of Covid-19

    Number of participants with symptomatic, lab-confirmed COVID-19

    Time frame: From date of enrolment to 14 days

07

Study locations

1 site
  • British Ayurvedic Medical Council
    London, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04395976
Lead sponsor
British Ayurvedic Medical Council
Collaborators
All Party Parliamentary Group - Indian Traditional Sciences, University of Warwick
Responsible party
Sponsor
First posted
May 20, 2020
Start date
May 10, 2020
Primary completion
Jun 10, 2020
Completion
Sep 1, 2020
Last update
Mar 2, 2021

Study contacts

Vishwes Kulkarni
principal investigator · University of Warwick
Amarjeet S Bhamra
study chair · All Party Parliamentary Group - Indian Traditional Sciences
Neha Sharma
study director · British Ayurvedic Medical Council

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion